SAFC Expands Continuous Flow Capabilities
News May 21, 2014
Now fully operational, the reactor has capacity to produce up to 150 kg of product per day and is complemented by a smaller pilot-scale continuous flow reactor being fabricated at the nearby Milwaukee facility.
“SAFC has invested in making these unique capabilities available to give customers access to products synthesized through reactions that were previously impractical or impossible to do with a conventional batch platform,” said Andreas Weiler, Director of Global Strategic Marketing for SAFC. “The reactors will allow SAFC to develop or scale up flow reactions for customers, eliminating the need for customers to install in-house flow capacity, saving them a great deal of money, space and time. This is also a much greener technology and substantially reduces the amount of chemicals and solvents employed in reactions.”
Continuous flow manufacturing is a lean manufacturing platform that provides customers access to as little or as much of a product as needed. The nature of this technique offers safer, seamless scale-up of a wider array of reactions compared to the batch platform. Additionally, this technique may aid customers in achieving process control, while helping to eliminate batch failures and minimize risks associated with handling hazardous chemicals.
The continuous flow reactor in Sheboygan, Wis., is currently online and SAFC is taking inquiries. Both of these reactors are supported by a multitude of research reactors located in the US and EU that provide support to customers from research to commercialization.
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Exploring Challenges in the Synthesis of Pharmaceutical DrugsNews
This summer, Wendell and Loretta Hess Professor of Chemistry Ram Mohan will travel to India and Hong Kong to deliver a series of post-graduate workshops on advanced concepts in organic synthesis.
His workshop “Advanced Concepts in the Synthesis of Pharmaceutical Drugs” at the Indian Institute of Technology Indore will explore the unique, real-world challenges in the pharmaceutical industry to synthesize drugs that are both commercially viable and eco-friendly.
Modern Alchemists are Making Chemistry GreenerNews
Ancient alchemists tried to turn lead and other common metals into gold and platinum. Modern chemists in Paul Chirik’s lab at Princeton are transforming reactions that have depended on environmentally unfriendly precious metals, finding cheaper and greener alternatives to replace platinum, rhodium and other precious metals in drug production and other reactions.READ MORE